Equities

Creo Medical Group PLC

Creo Medical Group PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)28.95
  • Today's Change-2.30 / -7.36%
  • Shares traded714.43k
  • 1 Year change-10.92%
  • Beta1.1892
Data delayed at least 20 minutes, as of Sep 20 2024 15:36 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments191344
Total Receivables, Net11108.76
Total Inventory8.109.338.50
Prepaid expenses0.701.090.37
Other current assets, total------
Total current assets383461
Property, plant & equipment, net9.10108.60
Goodwill, net192019
Intangibles, net7.108.088.69
Long term investments2.102.121.73
Note receivable - long term------
Other long term assets0.200.150.15
Total assets7775101
LIABILITIES
Accounts payable2.704.283.54
Accrued expenses2.403.605.18
Notes payable/short-term debt2.002.250
Current portion long-term debt/capital leases1.103.375.38
Other current liabilities, total1.903.995.63
Total current liabilities9.901720
Total long term debt5.206.075.18
Total debt8.301211
Deferred income tax1.402.001.79
Minority interest------
Other liabilities, total0.300.380.59
Total liabilities172627
SHAREHOLDERS EQUITY
Common stock0.400.180.18
Additional paid-in capital181150149
Retained earnings (accumulated deficit)(120)(100)(74)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(1.2)(0.54)(2.09)
Total equity604973
Total liabilities & shareholders' equity7775101
Total common shares outstanding361188188
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.